These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8394592)

  • 41. [Percutaneous treatment of hepatocellular carcinoma].
    Brú C
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S90-3. PubMed ID: 9102790
    [No Abstract]   [Full Text] [Related]  

  • 42. Percutaneous ethanol injection in bleeding hepatocellular carcinoma.
    Joly JP; Yzet T; Dupas JL; Capron JP
    AJR Am J Roentgenol; 1992 Dec; 159(6):1344-5. PubMed ID: 1332457
    [No Abstract]   [Full Text] [Related]  

  • 43. Percutaneous local therapies for hepatocellular carcinoma impair gastric function.
    Kinekawa F; Matsuda K; Masaki T; Kurokohchi K; Yoneyama H; Inoue H; Kurata H; Uchida Y; Watanabe S; Kuriyama S
    World J Gastroenterol; 2006 Jan; 12(1):157-8. PubMed ID: 16440439
    [No Abstract]   [Full Text] [Related]  

  • 44. Endoscopic ultrasound (EUS)-guided ethanol injection for hepatocellular carcinoma difficult to treat with percutaneous local treatment.
    Nakaji S; Hirata N; Iwaki K; Shiratori T; Kobayashi M; Inase M
    Endoscopy; 2012; 44 Suppl 2 UCTN():E380. PubMed ID: 23139031
    [No Abstract]   [Full Text] [Related]  

  • 45. [Percutaneous tumor ablation therapy for hepatocellular carcinoma: current status and future perspective].
    Shina S
    Nihon Shokakibyo Gakkai Zasshi; 2001 Jul; 98(7):809-13. PubMed ID: 11510082
    [No Abstract]   [Full Text] [Related]  

  • 46. Transthoracic percutaneous ethanol injection therapy for hepatocellular carcinomas located beneath the diaphragm.
    Shibata T; Kojima N; Tabuchi T; Itoh K; Ikai I; Yamaoka Y; Konishi J
    J Vasc Interv Radiol; 1998; 9(1 Pt 1):97-100. PubMed ID: 9468402
    [No Abstract]   [Full Text] [Related]  

  • 47. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383
    [No Abstract]   [Full Text] [Related]  

  • 48. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic imaging of 11C ethanol with PET in eight patients with hepatocellular carcinomas who were scheduled for treatment with percutaneous ethanol injection.
    Dimitrakopoulou-Strauss A; Strauss LG; Gutzler F; Irngartinger G; Kontaxakis G; Kim DK; Oberdorfer F; van Kaick G
    Radiology; 1999 Jun; 211(3):681-6. PubMed ID: 10352591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemobilia following percutaneous ethanol injection for hepatocellular carcinoma in a cirrhotic patient.
    de Sio I; Castellano L; Calandra M
    J Clin Ultrasound; 1992; 20(9):621-3. PubMed ID: 1331193
    [No Abstract]   [Full Text] [Related]  

  • 51. Subcutaneous metastasis following percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Yano S; Nakamura K; Yamane K; Kakinuma T; Asahina A; Tamaki K
    Acta Derm Venereol; 2001; 81(3):213-4. PubMed ID: 11558885
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination of interventional therapies in hepatocellular carcinoma.
    Lencioni R; Cioni D; Donati F; Bartolozzi C
    Hepatogastroenterology; 2001; 48(37):8-14. PubMed ID: 11269005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatocellular carcinoma: local-regional treatment].
    Fleig WE
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S102-3. PubMed ID: 12817337
    [No Abstract]   [Full Text] [Related]  

  • 54. Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.
    Arrivé L; Rosmorduc O; Dahan H; Fartoux L; Monnier-Cholley L; Lewin M; Poupon R; Tubiana JM
    AJR Am J Roentgenol; 2003 Jan; 180(1):159-62. PubMed ID: 12490495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy.
    Farina R; Pennisi F; Mazzone G; Pennisi M; Riva G; Foti PV; Puglisi C; Ettorre GC
    Radiol Med; 2009 Feb; 114(1):32-41. PubMed ID: 18820993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response of hepatocellular carcinoma to percutaneous ethanol injection: CT and MR evaluation.
    Lencioni R; Caramella D; Bartolozzi C
    J Comput Assist Tomogr; 1993; 17(5):723-9. PubMed ID: 8396598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous treatment of liver metastases.
    Adam A
    Acta Gastroenterol Belg; 2000; 63(2):163-4. PubMed ID: 10925452
    [No Abstract]   [Full Text] [Related]  

  • 58. [Percutaneous hot ethanol injection therapy (PHEIT)].
    Nakai M; Sato M; Kawai N
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():552-7. PubMed ID: 11762011
    [No Abstract]   [Full Text] [Related]  

  • 59. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.
    Livraghi T; Goldberg SN; Lazzaroni S; Meloni F; Solbiati L; Gazelle GS
    Radiology; 1999 Mar; 210(3):655-61. PubMed ID: 10207464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous hepatic infarction therapy for hepatocellular carcinoma.
    Imamura M; Shiratori Y; Sato S; Obi S; Okudaira T; Teratani T; Kato N; Shiina S; Omata M
    AJR Am J Roentgenol; 1998 Oct; 171(4):1031-5. PubMed ID: 9762991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.